Crispr Therapeutics shares tumble after significant earnings miss
Monica L. Greenberg, EVP, Policy & General Counsel at Liveperson Inc (NASDAQ:LPSN), sold 7,431 shares of common stock on July 28, 2025. The shares were sold at a price of $1.026, for a total transaction value of $7,624.
Following the transaction, Greenberg directly owns 699,270 shares of Liveperson Inc., which includes 558,749 unvested restricted stock units.
The sale was executed automatically by Liveperson to cover Greenberg’s tax obligations related to the vesting of restricted stock units.
In other recent news, LivePerson reported its Q1 2025 earnings, revealing a notable shortfall in earnings per share (EPS) compared to analyst forecasts. The company posted an EPS of -$0.24, which was significantly below the anticipated -$0.06. However, LivePerson’s revenue for the quarter reached $64.7 million, slightly exceeding the midpoint of its guidance. Additionally, LivePerson shareholders approved an amendment to the Amended and Restated 2019 Stock Incentive Plan, which increases the number of shares available for issuance by 5,340,000. This amendment also specifies that dividends or dividend equivalent rights will only be paid if the underlying award vests. In leadership news, LivePerson announced the appointment of Tony Zingale to its Board of Directors. Zingale brings over 40 years of experience in the technology industry, with a background in scaling enterprise software companies. These developments reflect the company’s ongoing strategic decisions and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.